TCG Crossover Management »

Jatt Ii Acquisition Corp shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Jatt Ii Acquisition Corp shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Jatt Ii Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Jatt Ii Acquisition Corp held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jatt Ii Acquisition Corp by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.3M 200k 11.36

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Comm (ABVX)
Tango Therapeutics Comm (TNGX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Immunovant Comm (IMVT)
Spyre Therapeutics Comm (SYRE)
Dianthus Therapeutics Comm (DNTH)
Mirum Pharmaceuticals Comm (MIRM)
Zai Lab Ltd- Adrs (ZLAB)
Amylyx Pharmaceuticals Comm (AMLX)
Monte Rosa Therapeutics Comm (GLUE)
Biocryst Pharmaceuticals Comm (BCRX)
Vor Biopharma Comm (VOR)
Tyra Biosciences Comm (TYRA)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding Jatt Ii Acquisition Corp

Dr. Jeffrey R. Jay, M.D.
Jupiter Topco
Balyasny Asset Management
RA Capital Management
ADAR1 Capital Management
Franklin Resources
Atika Capital Management
Citadel Advisors
Farallon Capital Management
Braidwell
Nantahala Capital Management
Affinity Asset Advisors
TCG Crossover Management
Spruce Street Capital
Millennium Management

View all funds holding Jatt Ii Acquisition Corp